|
US5482931A
(en)
|
1993-06-29 |
1996-01-09 |
Ferring Ab |
Stabilized pharmaceutical peptide compositions
|
|
AT409081B
(de)
|
2000-02-16 |
2002-05-27 |
Gebro Pharma Gmbh |
Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
|
|
EP1188443A1
(en)
|
2000-09-15 |
2002-03-20 |
Ferring BV |
Improved protocol for paracentesis
|
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
|
US20040153032A1
(en)
*
|
2002-04-23 |
2004-08-05 |
Garribotto John T. |
Dispenser for patient infusion device
|
|
US6991800B2
(en)
|
2002-06-13 |
2006-01-31 |
Vicuron Pharmaceuticals Inc. |
Antifungal parenteral products
|
|
US20040022792A1
(en)
*
|
2002-06-17 |
2004-02-05 |
Ralph Klinke |
Method of stabilizing proteins at low pH
|
|
CA2512788A1
(en)
*
|
2003-01-09 |
2004-07-29 |
Baxter Healthcare S.A. |
Safety containers for biologically active substances and method for producing said container
|
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
BRPI0611901A2
(pt)
|
2005-06-14 |
2012-08-28 |
Amgen, Inc |
composição, liofilizado, kit, e, processo para preparar uma composição
|
|
DK1984012T3
(en)
|
2006-02-13 |
2016-03-29 |
Ferring Bv |
USE OF peptidic vasopressin receptor agonists
|
|
GB0700523D0
(en)
|
2007-01-11 |
2007-02-21 |
Insense Ltd |
The Stabilisation Of Proteins
|
|
CN101677948A
(zh)
|
2007-06-07 |
2010-03-24 |
纳斯泰克制药公司 |
卡贝缩宫素鼻用制剂和治疗孤独症的方法
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
WO2009037586A2
(en)
|
2007-08-14 |
2009-03-26 |
Ferring B.V. |
Use of peptidic vasopressin receptor agonists
|
|
EP2203172A2
(en)
|
2007-09-28 |
2010-07-07 |
Ferring B.V. |
Use of v2 receptor antagonists in combination with vasopressinergic agonists
|
|
WO2009062174A1
(en)
|
2007-11-08 |
2009-05-14 |
University Of Utah Research Foundation |
Use of angiogenesis antagonists in conditions of abnormal venous proliferation
|
|
US8420081B2
(en)
|
2007-11-30 |
2013-04-16 |
Abbvie, Inc. |
Antibody formulations and methods of making same
|
|
US8815232B2
(en)
|
2008-08-26 |
2014-08-26 |
Kyon Biotech Ag |
Compositions and methods for treating cancer
|
|
EP2161030A1
(en)
*
|
2008-09-09 |
2010-03-10 |
Rijksuniversiteit te Groningen |
Oxytocin formulations and uses thereof
|
|
EP2344200A2
(en)
*
|
2008-09-19 |
2011-07-20 |
Nektar Therapeutics |
Modified therapeutics peptides, methods of their preparation and use
|
|
MX2011004199A
(es)
|
2008-10-20 |
2011-05-24 |
Abbott Lab |
Anticuerpos que unen a il-18 y metodos para purificar los mismos.
|
|
US20100203014A1
(en)
|
2009-02-04 |
2010-08-12 |
Aegis Therapeutics Llc |
Zwitterionic buffered acidic peptide and protein formulations
|
|
CN102369296A
(zh)
|
2009-03-09 |
2012-03-07 |
生物蛋白有限公司 |
Mirac蛋白
|
|
CN104434894A
(zh)
|
2009-06-08 |
2015-03-25 |
Ucl商业有限公司 |
使用l-鸟氨酸苯乙酸盐治疗门静脉高压和恢复肝功能
|
|
WO2010149213A1
(en)
*
|
2009-06-24 |
2010-12-29 |
Nokia Siemens Networks Oy |
Network element for changing the timeslot type according to the received information
|
|
US8613892B2
(en)
*
|
2009-06-30 |
2013-12-24 |
Abbott Diabetes Care Inc. |
Analyte meter with a moveable head and methods of using the same
|
|
KR20130026504A
(ko)
|
2010-07-14 |
2013-03-13 |
큠버랜드 에멀징 테크놀로지스 아이앤씨 |
트롬복산-a2 수용체 길항제를 이용한 간신증후군 및 간성뇌증의 치료방법
|
|
JO3400B1
(ar)
|
2010-09-30 |
2019-10-20 |
Ferring Bv |
مركب صيدلاني من كاربيتوسين
|
|
CN102440957B
(zh)
|
2011-12-16 |
2013-09-25 |
深圳市健元医药科技有限公司 |
醋酸特利加压素鼻腔喷雾剂及其制备方法
|
|
WO2013106072A1
(en)
|
2012-01-10 |
2013-07-18 |
Sorbent Therapeutics, Inc. |
Compositions comprising crosslinked cation-binding polymers and uses thereof
|
|
JO3109B1
(ar)
|
2012-05-10 |
2017-09-20 |
Ferring Bv |
منبهات لمستقبلات v1a
|
|
CA2891281C
(en)
|
2012-11-12 |
2023-11-28 |
The Regents Of The University Of Colorado, A Body Corporate |
Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis
|
|
EP2988770A4
(en)
|
2013-04-26 |
2016-12-14 |
La Jolla Pharma Co |
COMPOSITIONS AND METHOD FOR TREATING KIDNEY FAILURES
|
|
US20150056194A1
(en)
|
2013-08-21 |
2015-02-26 |
Georgia Regents Research Institute, Inc. |
Modified green tea polyphenols and methods thereof for treating liver disease
|
|
US20150328317A1
(en)
|
2014-05-13 |
2015-11-19 |
Eagle Pharmaceuticals, Inc. |
Aqueous buffer-free bivalirudin compositions
|
|
US20200046798A1
(en)
|
2014-10-24 |
2020-02-13 |
Mallinckrodt Hospital Products IP Limited |
Method of treating patients with hepatorenal syndrome type 1
|
|
US10335452B2
(en)
|
2014-10-24 |
2019-07-02 |
Mallinckrodt Hospital Products IP Limited |
Method of treating patients with hepatorenal syndrome type 1
|
|
US20200237856A1
(en)
|
2014-10-24 |
2020-07-30 |
Mallinckrodt Hospital Products IP Limited |
Method of treating patients with hepatorenal syndrome type 1
|
|
WO2017150824A1
(ko)
|
2016-03-03 |
2017-09-08 |
가천대학교 산학협력단 |
마이크로 니들 및 이의 제조방법
|
|
CN109462995A
(zh)
*
|
2016-05-04 |
2019-03-12 |
波涛生命科学有限公司 |
生物活性剂的方法和组合物
|
|
GB201721846D0
(en)
|
2017-12-22 |
2018-02-07 |
Arecor Ltd |
Novel composition
|
|
WO2019180561A1
(en)
*
|
2018-03-20 |
2019-09-26 |
Mankind Pharma Ltd. |
Stable pharmaceutical composition of vasopressin
|
|
MX2020013389A
(es)
*
|
2018-06-15 |
2021-03-31 |
Ferring Bv |
Composiciones de terlipresina y usos de las mismas.
|
|
CN108659104B
(zh)
*
|
2018-07-03 |
2020-06-09 |
北京市新里程医药科技有限公司 |
一种特利加压素的制备方法及其药物组合物
|
|
CN109010795B
(zh)
|
2018-09-12 |
2021-10-22 |
南京康舟医药科技有限公司 |
醋酸特利加压素注射液以及其制备方法
|
|
US20220080023A1
(en)
|
2018-12-21 |
2022-03-17 |
Arecor Limited |
Novel composition
|